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Purpose: The outer limiting membrane (OLM) is considered to play a role in maintaining 
the structure of the retina through mechanical strength. However, the observation of junction 
proteins located at the OLM and its barrier permeability properties may suggest that the OLM 
may be part of the retinal barrier.
Material and methods: Normal and diabetic rat, monkey, and human retinas were used 
to analyze junction proteins at the OLM. Proteome analyses were performed using immuno-
histochemistry on sections and flat-mounted retinas and western blotting on protein extracts 
obtained from laser microdissection of the photoreceptor layers. Semi-thin and ultrastructure 
analyses were also reported.
Results: In the rat retina, in the subapical region zonula occludens-1 (ZO-1), junction adhesion 
molecule (JAM), an atypical protein kinase C, is present and the OLM shows dense labeling 
of occludin, JAM, and ZO-1. The presence of occludin has been confirmed using western blot 
analysis of the microdissected OLM region. In diabetic rats, occludin expression is decreased 
and glial cells junctions are dissociated. In the monkey retina, occludin, JAM, and ZO-1 are also 
found in the OLM. Junction proteins have a specific distribution around cone photoreceptors 
and Müller glia. Ultrastructural analyses suggest that structures like tight junctions may exist 
between retinal glial Müller cells and photoreceptors.
Conclusions: In the OLM, heterotypic junctions contain proteins from both adherent and 
tight junctions. Their structure suggests that tight junctions may exist in the OLM. Occludin 
is present in the OLM of the rat and monkey retina and it is decreased in diabetes. The OLM 
should be considered as part of the retinal barrier that can be disrupted in pathological condi-
tions contributing to fluid accumulation in the macula.
Keywords: retinal barrier, OLM, junctions, adherent, tight, diabetes
Introduction
Exchanges between the retina and the circulation are controlled by the blood–retinal 
barrier at the inner side, which is made up of the retinal vessels surrounded by peri-
cytes and glial cells, and by the outer retinal barrier which is constituted by a single 
layer of retinal pigment epithelial cells (RPE) at the outer side. Tight junctions (TJ) 
located between endothelial cells in retinal vessels and in retinal pigment epithelial 
cells contribute to protect the retina towards circulating molecules and cells, to confer 
immune privilege to the eye, and to limit the penetration of drugs into the retina. 
Particularly, the RPE cells are responsible for the hydro-ionic exchanges between the 
choriocapillaries and the outer retina. Junctions in RPE cells are composed, like in 
other epithelia, by TJ, adherens junctions (AJ) and desmosomes. TJ and AJ differ by 
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their constitutional proteins and their spatial organization and 
their permeability.1,2 TJ are located at the more apical side of 
the epithelium and are composed of a heterogeneous complex 
of transmembrane proteins from the occludin, the claudin, 
and the junctional adhesion molecules (JAM). Intracellular 
scaffold proteins such as zonula occludens (ZO) link these 
molecules to the actin cytoskeleton providing structural 
integrity to the cells3 (Figure 1). In the RPE cells, JAM-A 
and C are located in the TJ complexes. JAM-A controls 
apicobasal polarization of the epithelium and regulates its 
permeability. JAM-C are mostly implicated in the formation 
of TJ by recruiting the intracellular proteins in the polar-
ization and it allows the basal to apical transmigration of 
granulocytes.5 Directly beneath the TJ are the AJ that consist 
of the transmembrane protein E-cadherin, and intracellular 
components, p120-catenin, β-catenin, and α-catenin. Cadher-
ins are transmembrane proteins that link to contact cells and 
interact with many cytoplasmic proteins.6 The AJ performs 
multiple functions including initiation and stabilization of 
cell–cell adhesion, regulation of the actin cytoskeleton, 
intracellular signaling, and transcriptional regulation. More 
specifically, AJ are required to form and stabilize the TJ 
through the ZO-1 that can also be a component of AJ and 
interact with the actin cytoskeleton.7 Desmosomes link the 
AJ to intermediate filaments (Figure 1). Different protein 
kinase C (PKC), but more specifically atypical PKCζ such 
as PKCζ associates and regulates the tight junctions and 
colocalizes with ZO-1. The assembly of ZO-1 is dependant 
on PKCζ activity in the mouse embryo.8 In endothelial cells 
that are not linked by TJ, AJ, which is mostly composed 
by VE-cadherin, control the vessel permeability. Vascular 
endothelial growth factor (VEGF), among other cytokines, 
induce VE-cadherin phosphorylation and increase vessel 
permeability and leukocyte diapedesis.9
In the vertebrate retina, AJ and desmosomes have also been 
identified at the outer limiting membrane (OLM). Indeed, the 
apical processes of Müller cells are attached to each other and 
to the inner segments of the photoreceptor cells by continuous 
heterotypic AJ type that collectively form the OLM.10 It has 
generally been accepted that this “membrane” is continu-
ous throughout the entire retina. However, one observation 
reported that in the center of the fovea centralis of nonprimate 
retinas, OLM may contain circumscribed areas in which AJ are 
lacking between few cone inner segments and apices of Müller 
cells.10 Whether these interruptions also exist in the human 
fovea remain to be demonstrated. In an unusual role for this 
type of junction, AJ in the OLM also provide a semipermeable 
barrier, preventing the diffusion of some proteins out of the 
extracellular space that surrounds the inner and outer segments 
of the photoreceptors. The barrier property of the OLM to 
protein diffusion was demonstrated by subretinal injection of 
proteins.11 In the rabbit retina, the threshold for diffusion was 
a pore radius estimated between 30 and 36 Angströms.10,12,13 
Fluorescein isothiocyanate dextran 10-S (radius 22A) diffused 
readily into the vitreous but the diffusion of FITC dextran 
70-S (radius 58A) and 150-S (radius 85) both larger than 
albumin (radius 35) was markedly slower, and roughly 80% 
of the 150-S dextran was still present in the subretinal space 
after three days.14 The semipermeable barrier function of OLM 
AJ was related to the unusual and asymmetrical aggregation of 
actin, myosin, and alpha-actinin in the Müller cells that could 
also contribute to support the motile photoreceptors.15
Interestingly, JAM proteins were recently found in the 
OLM of mice retinas. Particularly, using immunolocaliza-
tion studies JAM-C was found at the OLM and at the apical 
membranes of Müller cells and RPE cells. In JAM-C knock 
out mice, a normal phenotype was attributed to the expression 
of JAM-A that could have redundant function. In the all-cone 
retina of the Nrl(-/-) mouse, JAM-C was overexpressed sug-
gesting a specific role for JAM proteins in cone polarization 
and function.16
Taken together, these observations suggest that AJ at 
the OLM may be of a particular type, with components and 
functions of TJ.
In order to explore this hypothesis, we have used immu-
nohistochemistry of retina sections, western blot analysis 
from tissue-extracted laser microdissections of specific retinal 
layers, flat-mounted rat and monkey retinas and semi- and 
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Figure 1 schematic representation of apical junction complex (AJC) in epithelial 
cells. Zonula occludens comprises the tight junctions constituted by members of the 
transmembrane claudin, occluding, and JAM proteins. Cytoplasmic proteins such as 
ZO and PAR3,6 link them to the cytoskeleton. PKCζ phosphorylates these proteins 
and thereby intervenes in the junction proteins complexes formation.
Abbreviations: JAM, junctional adhesion molecules; PKC, protein kinase C.
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ultrathin human macula sections to evaluate the presence of 
different junction proteins and structures. Moreover, we have 
evaluated potential changes of the OLM induced by diabetes 
in one-year diabetic Goto–Kakizaki rats.
Material and methods
Animals
The use of animals adhered to the ARVO statement for 
Ophthalmic and Vision Research and protocols were approved by 
the ethical committee of René Descartes University of Paris.
To investigate in vivo the effects of diabetes on the OLM, 
we used Goto–Kakizaki (Male GK Taconic rat) developing 
spontaneous type 2 diabetes at approximately 14–16 weeks 
of age. We chose 11 rats GK, 12 months of age, which 
developed a hyperglycemia (3 mg/dL) and 16 normogly-
cemic rats (1.30 mg/dL) as control. Five rats (10 eyes) 
from each group were used for western blot analysis. The 
other eye rats were used for immunohistochemistry study 
on cryosections.
One monkey (1-year-old male Chlorocebus aethiops) was 
used. One eye was used for cryosections and the other one for 
retinal flat mounts. We also have used two human eyes from 
donors to perform semi- and ultrathin analyses.
Animals were sacrificed by CO
2
 inhalation and the eyes 
were removed either for cryosections or for retinal flat 
mounts.
Western blotting
Western blots were performed on proteins extracted either 
from the entire neuroretina (at least six eyes from control or 
diabetic rats) and on proteins extracted from the photorecep-
tor layers microdissected on cryosections using laser (at least 
six eyes from control or diabetic rats).
Neuroretinas (10 per group) were homogenized in lysis 
buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM 
EGTA, 150 mM NaCl, 0.5% Nonidet P40, 1% Triton X-100, 
β-mercaptoethanol) containing protease inhibitor cocktail 
(from Roche, France). The protein concentration of the 
resulting lysates was determined using a Bradford assay. 
40–50 µg of proteins were subjected to SDS-PAGE in a 12% 
polyacrylamide gel and electroblotted onto nitrocellulose 
membranes (Schleicher and Schuell BioScience, Dassel, 
Germany), anti-glutamine synthetase MAB 302 (Chemicon 
Technology, Temecula, CA, USA), antioccludin 71–1500 
(Zymed, San Francisco, CA, USA), Rat anti α-tubulin, clone 
YL1/2 (Serotec, Düsseldorf, Germany). They were then incu-
bated with corresponding secondary antibodies: peroxidase-
conjugated F(ab)2 fragment (Caltag, Burlingame, Canada). 
Immunoreactive bands were detected with the ECL Western 
Blotting Detection Reagents Kit (Amersham Biosciences, 
Orsay, France).
The relative abundance of individual proteins identified 
was quantified by scanning densitometry.
Laser microdissection
OLM region was isolated from neuroretina by laser microdis-
section of outer retina with a Leica AS LMD system (Leica, 
Solms, Germany) as described by Burbach and colleagues17 
and protein extracts from at least 30 sections of 40 µm per 
eye were also used for immunoblot analysis.
immunohistochemistry
For cryosections, rats or monkey eyes were fixed in 4% para-
formaldehyde in phosphate-buffered saline (PBS), embedded 
in optimal cutting-temperature (OCT) compound (Tissue-
Tek; Miles Inc., Bayer Diagnostics, Puteaux, France) and 
frozen in liquid nitrogen; we cut 8 µm anteroposterior cryo-
sections onto gelatin-coated slides. These slides were stored 
at -20 °C until immunohistochemical analysis. Specimens 
were incubated overnight at 4 °C with primary antibodies 
diluted in PBS supplemented with 10% fetal calf serum (FCS) 
and 0.1% Triton X-100. The primary antibodies used were: 
anti PKCζ (C-20) sc-216 (Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA, USA), Anti-ZO1 (H-300) sc-10804 (Santa 
Cruz Biotechnology, Inc.), anti-occludin 71–1500 (Zymed, 
San Francisco, CA, USA), anti-glutamine synthetase MAB 
302 (Chemicon Technology), rhodamine phalloidin R415 
(Molecular Probes, Eugene, OR, USA), and Fluorescein 
Peanut Agglutinin FL-1071 (Vector Laboratories, ABCYS, 
Paris, France).
After incubation with the primary antibodies, slides 
were washed with PBS, and incubated with secondary 
antibodies for one hour at room temperature. Alexa Fluor 
488-conjugated goat anti-rabbit F(ab)2 fragment or Alexa 
Fluor 594-conjugated goat anti-mouse F(ab)2 fragment was 
used as the secondary antibody for immunocytochemistry 
(Molecular Probes). Sections were incubated with DAPI to 
stain cell nuclei and were finally observed under a fluores-
cence microscope (BX51; Olympus, Rungis, France) or a 
confocal microscope (LSM 510 laser scanning microscope; 
Zeiss, Le Pecq, France). Each immunostaining was repeated 
at least three times and staining omitting the primary antibody 
served as the negative control.
For flat mounts, rats and monkey eyes were enucleated, 
fixed in 4% paraformaldehyde (PFA) for 15 minutes at room 
temperature, and sectioned at the limbus. The cornea and 
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lens were discarded. The retinas were carefully peeled from 
the RPE/choroid/sclera. Retinas were fixed for additional 
15 minutes in acetone at -20 °C and incubated with the indi-
cated primary and secondary antibodies, each for one hour 
at room temperature. The retinas were incised, flat mounted, 
and viewed with a fluorescence microscope.
Serial sections of eyes were mounted on slides. On 
average, 10–15 sections per eyes were analyzed for each 
expressed protein that was quantified. Each group had a 
minimum of five eyes. The experiment was repeated in trip-
licate. Fluorescent images of sections were scanned at the 
same magnification and exposure conditions. Quantification 
was done by Image J software (National Institutes of Health, 
Bethseda, MD, USA). First, the total area of the section was 
measured, and then glutamine synthetase (Alexa 594) and 
occludin (Alexa 488) specific areas were determined on the 
same section. The percentage of glutamine synthetase- and 
occludin-specific area was then determined.
Semi- and ultrathin sections
Enucleated eyes were opened with a blade at the pars plana 
and immediately fixed in glutaraldehyde for two hours and 
then dissected with a 6-mm biopsy punch to section the pos-
terior pole. Tissues were fixed in glutaraldhehyde, processed 
in cacodylate buffer, and embedded in plastic. Semithin sec-
tions were obtained using a microtome and counter-stained 
with hematoxylin–eosin. These sections were analyzed using 
phase contrast microscopy. Specific sites of interest were 
further processed for transmission electron microscopy. 
Ultrathin sections were obtained using an ultramicrotome 
and counter-stained with uranyl acetate.
statistical analysis
Results are expressed as means ± standard deviation and 
statistical analysis was performed using a Mann–Whitney 
U nonparametric test. P  0.05 was considered significant.
Results
We have used different antibodies to label proteins of the 
tight and adherent junctions as well as glial Müller cells and 
cone photoreceptors.
Occludin is expressed in the OLM of 
normal rats and decreased in the OLM  
of diabetic rats
As shown in Figure 2, two different zones can be differen-
tiated in the normal rat retina by their differential protein 
localization (Figures 2A–B). The subapical region of the 
photoreceptor (SAR) is labeled with the antiphalloidin 
antibody that recognizes the actin filaments of the cytoskel-
eton. Indeed while cones are labeled by the peanut agglutinin 
(PNA) (Figure 2A in green), a well defined organization of 
actin forms a belt just below the OLM (Figure 2A in red) and 
photoreceptor inner segments. Interestingly, PKCζ, known 
to control tight-junctions, is also strongly expressed in the 
subapical region of normal rats (Figure 2B in green).
In the second region, located just below the outer nuclear 
layer, the apical membranes of Müller cells labeled with 
glutamine synthetase (Figure 2B in red) also express PKCζ 
(Figure 2B in yellow for colocalization) and form dense areas 
at the OLM (Figure 2B).
In hyperglycemic diabetic rats, the SAR is altered and the 
actin belt shows irregularities (Figure 2C). Note that cone 
photoreceptors are disorganized and that PKCζ expression is 
decreased and irregularly distributed in the SAR (Figure 2D, 
arrows).
Controls omitting the first antibodies were negative 
(Figures 2E and F) demonstrating the specificity of the 
immunolabeling.
In the OLM region, occludin is expressed and colocalized 
with glutamine synthetase in condensed areas (Figures 3A, 
3B, and 3C arrows). Indeed, occludin forms a continuous 
line at the OLM with some condensed zones (Figure 3B, 
arrows and inset). This demonstrates that in the normal rat 
retina, proteins usually known to be expressed in tight junc-
tions are present.
In 1-year-old hyperglycemic GK diabetic rats, occludin 
expression is decreased, and instead of forming a continu-
ous line, displays focal zones of discontinuities (Figure 3D, 
arrows). Colabeling of occludin with glutamine synthetase 
shows that glial Müller cells are swollen and that occludin can 
be observed in the cytoplasm of the cells suggesting internal-
ization of occludin inside the cells (Figure 3E, inset).
Quantification of fluorescence confirmed that glutamine 
synthetase (Figure 3F) and occludin expression (Figure 3G) 
are significantly reduced in the retina from hyperglycemic 
diabetic rats.
To ascertain occludin expression at the OLM, western blot 
analyses were performed on protein extracts specifically only 
from the photoreceptors layers, excluding therefore occludin 
expressed in endothelial cells. Using this technique, we show 
that occludin is present in the OLM of normal rat retina 
and that its expression is significantly decreased in diabetic 
conditions (Figure 4A).
Moreover, as shown on western blots performed on 
the entire retina, glutamine synthetase is also significantly 
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Figure 2 immunohistochemistry on normoglycemic and hyperglycemic 1-year-old goto–Kakizaki rats. A and C: Phalloidin and peanut agglutinin (PnA) colabeling in normo- or 
hyperglycemic rat sections. B and D:  Atypical PKCζ colabeled with glutamine synthetase (gs) a glial Müller marker in normo or hyperglycemic rat sections. E and F: nega-
tive controls omitting the first antibodies. Note the irregular actin (phalloidin staining) and cone photoreceptor disorganization and OLM rupture (arrow) in hyperglycemic 
conditions (C) and (D).
Notes: in all sections nuclei are stained with DAPi (blue). Bar = 10 µm for all sections.
Abbreviations: OnL, outer nuclear layer; OLM, outer limiting membrane; is, inner segment; Os, outer segment; sAR, subapical region.
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Figure 3 Occludin is expressed and colocalized with glutamine synthetase at the OLM. gs red (A) and occludin green (B) merged (C). note de decrease of both occludin 
and gs staining in hyperglycemic conditions (D, E). gs (F) and occludin (G) immunohistochemistry staining quantification.
Abbreviations: OnL, outer nuclear layer; OLM, outer limiting membrane; gs, glutamine synthetase.
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decreased in diabetic retina, suggesting the presence of 
Müller glial cells (Figure 4B).
A closer examination of the OLM region by confocal 
imaging of flat-mounted retina from normal and diabetic rats 
showed that the glial Müller cells labeled by glutamine synthe-
tase create a regular and dense network around photoreceptors 
at the nuclei and subapical level (Figure 5A). Colabeling with 
glutamine synthetase and occludin confirmed that occludin 
is located between glial Müller cells and photoreceptors 
and between glial Müller cells (Figure 5C). Some occludin 
condensations were observed between glial cells and some 
photoreceptors (Figure 3C, arrows). In the diabetic rat retinas, 
a very different pattern of the retinal Müller cells network was 
observed with swelling of the glial cells forming large cysts 
(Figure 5B, arrows). Occludin is decreased in the junctions 
between retinal Müller cells that look open (Figure 5D arrow) 
and between Müller cells and photoreceptors.
Because the structure of the macula is different from the 
structure of the rat retina, we examined primate and human 
retina at the macula.
Junction proteins are expressed  
in the OLM of the monkey retina
Contrary to what was previously thought, retinal glial Müller 
cells are extremely dense in the primate macula where 
they form a concentric network on flat-mounted retina 
(Figure 6A). In the fovea, only elongated cones and specific 
cone-shaped Müller cells are present (Figure 6B). By two-
dimensional reconstruction of confocal imaging of PNA-GS 
labeled flat-mounted retina, we could find that indeed cone 
outer segments are elongated and that the inner segment and 
the SAR is shorter. Retinal Müller glial cell apices are almost 
in contact with the cone outer segment leading to a decrease 
in the glial free SAR that surrounds the fovea (Figure 6C).
Flat mounts of the perifoveal region showed a very dense 
belt of actin (phalloidin-labeled) in the SAR region just above 
the cone segments (labeled with PNA in red on Figure 7A). 
Sections of the monkey retina showed that protein usually 
known to belong to TJ are present. PKCζ, known to associate 
with ZO-1 is present and condensed in the OLM and surrounds 
cone outer segments (Figure 7B, 7C). ZO-1 has a very interest-
ing distribution in the OPL and specifically all around cone 
photoreceptors as shown by double PNA and ZO-1 labeling. 
ZO-1 seems to concentrate in the cytoplasma at the SAR region 
(Figure 7D, arrow) and to localize at the membrane of the 
cone at the OLM and at the level of cones nuclei (Figure 7D). 
Colabeling of ZO-1 with GS shows that ZO-1 colocalizes with 
GS at the OLM and around the cones suggesting that specific 
junctions may exist at this level (Figure 7E, arrows).
As observed in the rat retina, occludin is expressed in 
the retinal glial Müller cells at the OLM (Figure 7F, arrows) 
where it is organized as focal densification between glial 
apices and the photoreceptors (Figure 7F, inset).
In the monkey retina, JAM-A has a distribution very simi-
lar to that of ZO-1. It is found surrounding cones specifically 
at the OLM and condensed in the cytoplasma at the SAR level 
(Figure 7G). JAM-A at the OLM colocalizes with glial Müller 
cells (labeled by GS) at junctions between the apical ends of 
glial cells and cone photoreceptors (Figure 7G, arrows). All 
together these results suggest that TJ-like structures may exist 
in the OLM and that those structures may have differences 
between glial Müller cells and cones or rod photoreceptors.
Ultrastructural differences in the OLM 
between the peripheral versus foveal 
region of the human retina
In order to evaluate whether specific junction-like structure 
could also be detected in a human macula, we analyzed 
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Figure 4 Western blotting analysis and quantification of occludin and GS expression in normal and diabetic conditions. (A) Occludin and tubulin immunoreactivity on protein 
extracts from OLM region isolated by laser microdissection of outer normal (Ctl) and diabetic (Dia) retina. (B) gs and tubulin immunoreactivity on total protein extracts from 
normal (Ctl) and diabetic (Dia) retina. These data confirm the expression decrease of both occluding and GS proteins showed by immunochemistry analysis.
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Figure 5 Confocal imaging of the OLM labeled with glutamine synthetase (gs) and occludin. (A) Confocal imaging of the OLM of a normal rat from the sAR towards the 
OnL (lower panel). (B) Confocal imaging of the OLM of a diabetic rat from the sAR towards the OnL (lower panel), showing large cysts due to glial cells swelling (arrows). 
(C) Confocal imaging of the OLM labeled with gs and occludin in a normal rat. Occludin is located around photoreceptors at the glial membrane and between glial Müller 
cells. (D) Confocal imaging of the OLM labeled with gs and occludin in a diabetic rat. The OLM has a very content high of occludin as compared to the normal rat. Junctions 
seem disrupted between glial Müller cells (arrow).
Abbreviations: gs, glutamine synthetase; OLM, outer limiting membrane; OnL, outer nuclear layer; sAR, subapical layer.
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semithin sections of two human maculae (Figure 8A). Very 
close examination of the macula OLM showed that while 
a dense continuous line of “junction-like” structure can be 
observed in the peripheral macula (Figure 8B), this pattern 
appeared different in the fovea where circumscribed con-
densed areas could be observed between longer cone outer 
segments (Figure 8C, black arrows). These areas could cor-
respond to junctions between longer glial Müller apices and 
the cone outer segments. The scheme on Figure 8D illustrates 
this hypothesis.
Figure 9 represents ultrathin sections of the equato-
rial retina of a human eye at the OLM level. Glial Mül-
ler cells are joined to each other by homotypic AJ, and 
are in contact with photoreceptors by heterotypic AJ 
(Figure 9A, arrows). Higher magnification of the hetero-
typic AJ showed that while a dense network of actin and 
intermediate filaments are observed in the glial side of the 
junction (Figure 9B, arrows), no such networks exist at the 
photoreceptor side of the junction (Figure 9B, arrowheads). 
Instead, tight-like junction densifications can be identified 
(Figure 9B, arrowheads).
In the fovea, junctions between glial Müller cells and 
photoreceptors in the OLM are shorter and have the typical 
structure of desmosomes with the dense intermediate filament 
extensions (Figure 10A, inset). Glial Müller apices send pro-
longations in between the cones outer segments (Figure 10B, 
arrow and inset) and tight-like structures can be observed 
below these glial extensions (Figure 10C, inset).
In epithelial cells, distinct protein localization allows to 
clearly distinguish between the TJ and the AJ (Figure 11). 
In the OLM–SAR region, proteins known to be expressed 
in TJ are detected and probably assemble differently in the 
junctions between Müller cells and rods, Müller cells and 
cones, and between cones and cones.
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Figure 7 Junction protein immunohistochemistry of the monkey retina. (A) Flat-mounted retina immunostained with phalloidin (actin marker) and peanut agglutinin (cone 
marker) showing the dense actin belt around photoreceptor sAR. (B) PKCζ immunohistochemistry showing that PKCζ is localized at the OLM and surrounds cones outer 
segments. (C) PnA and PKCζ co-staining confirms that PKCζ surrounds cone outer segments. (D) ZO-1/PnA immunohistochemistry showing that ZO-1 surrounding cones 
are condensed in the sAR and inner segment and are not expressed in rods. (E) ZO-1/gs immunohistochemistry showing that ZO-1 is expressed in glial Müller cells membranes 
around cones and in junctions at the OLM. (F) Occludin/gs immunohistochemistry showing co-staining of occludin in the glial Müller cells apical processes around photorecep-
tor nuclei in the OnL. (G) JAM-A/gs immunohistochemistry showing that JAM-A follows ZO-1 distribution at photoreceptors and Müller glia junctions in the OnL.
Notes: nuclei are stained with DAPi (Blue). Bar = 10 µm for all sections.
Abbreviations: OnL, outer nuclear layer; OLM, outer limiting membrane; is, inner segment; Os, outer segment; sAR, subapical region.
Monkey retina
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Figure 6 Flat-mounted monkey macula.  (A) GS labeling of a flat-mounted macula showing the very dense concentric disposition of glial Müller cells around the fovea centralis. 
Inset shows a higher magnification of the fovea where glial cells are still present but out of focus. Nuclei are stained in blue. (B, C) histological section of a monkey macula 
and computerized reconstitution of GS/PNA-labeled flat-mounted monkey fovea. Outer segments of central cones (green) are longer and in contact with glial Müler cells 
apical processes (red).
Abbreviation: gs, glutamine synthetase.
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Figure 8 semithin sections of a human macula. (A) OLM in the macular region. (B) OLM in the peripheral macula. (C) OLM in the fovea. (D) schematic hypothesis of glial 
extensions and potential junctions with cone outer segments.
Notes: Bar = 10 µm for all sections.
Abbreviations: OnL, outer nuclear layer; OLM, outer limiting membrane; is, inner segment; Os, outer segment; sAR, subapical region.
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Discussion
Understanding the exact components of retinal barriers and 
the specific differences that may exist between the peripheral 
retina and the macula is a prerequisite for understanding why 
edema locates in the macula. The OLM is not considered as 
part of the outer retinal barriers but plays a role in maintain-
ing the structure of the retina through mechanical strength. 
Whilst the RPE barrier has been well characterized, limited 
and contradictory data are available regarding the OLM. 
Moreover, because the structure of the retina differs between 
species and from the periphery to the macula in humans, no 
extrapolation can easy be made among species. Several previ-
ous studies performed in different species have all shown that 
when proteins are injected in the subretinal space, depending 
on their molecular weight, proteins would or would not cross 
the OLM and diffuse in the inner retina and vitreous, suggest-
ing that the OLM could serve as a gate for macromolecule 
transport in the retina and act as a semipermeable barrier.
In epithelial cells, apical TJ serve as solute permeability 
barriers, and AJs have an adhesive role to maintain tissue 
integrity against mechanical stress.18 The TJs and AJs that 
usually comprise apical junction complexes (AJCs) are widely 
thought to consist of distinct and largely nonoverlapping sets 
of proteins. Claudins constitute the major diffusion barrier 
of TJ19 and contribute to maintain cell polarity with occlu-
din and cytoplasmic proteins such as ZO family member 
domains in the plasma membrane.20 Proteins that constitute 
the AJ (mostly cadherins and catenins) do not play a role in 
the diffusion barrier.20
In order to understand the molecular basis of the observed 
OLM permeability barrier, we have looked for TJ protein 
expression in the OLM in the rat and the monkey retina. In 
both species, TJ proteins are expressed and differentially 
distributed. While actin forms a belt in the SAR of both rods 
and cones, occludin localizes at the OLM and form a linear 
pattern around photoreceptors and between glial Müller cells 
prolongations at the OLM level. As observed on confocal 
microscopy, occludin is located at the membrane of Müller 
cells. The mechanisms of occludin assembly to the TJ are still 
not fully understood. The phosphorylated state of occludin 
(on Ser/Thr or Tyr residues) by atypical PKC such as PKCζ 
and PKCλ/ι may regulate its interactions with ZO-1 and 
Clinical Ophthalmology 2010:4192
Omri et al Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
Figure 9 Ultrathin sections of the OLM in the equatorial human retina. (A) junctions at the OLM between glial/glia and glia/photoreceptors. (B) Higher magnification of a 
heterotypic junction between a Müller glia and a photoreceptor showing asymmetrical disposition of intermediate filaments and tight-like structures (arrowheads).
Abbreviation: OLM, outer limiting membrane.
possibly other TJ proteins.21 Interestingly, PKCζ was found 
in the SAR of both rods and cones in the rat retina. In the 
monkey retina, it was also expressed in the SAR of rods and 
cones but located in dense regions between rods and cones 
nuclei at the OLM and at the membrane of the cone inner 
segment. In the retina, PKCζ could assemble with junction 
proteins or ZO-1 as described in the mouse embryo.22 Con-
trary to ZO-1 previously found in the OLM of mice retina,23 
occludin was not previously detected in the OLM of the 
mouse retina.24 In the rat and in the monkey retina, using both 
sections and flat-mounts, occludin was clearly identified at 
the OLM. These differences can be explained by the different 
antibodies used and by species differences.
In our experiments, ZO-1 was highly expressed in the rat 
(not shown) and monkey retina. In the monkey retina, ZO-1 
was found in some ganglion cells (not shown) and in the OPL 
as shown by Puller and colleagues.25 In the photoreceptors, 
ZO-1 was expressed in the cones as shown by the colabeling 
with PNA, allowing the cone to be followed from its inner 
segment to the OPL. A denser distribution was observed in 
the SAR. Most importantly, ZO-1 also was expressed at the 
junction between glial Müller cells and cones at the OLM, in 
junction-like structures, where occludin was also localized.
JAM are members of the immunoglobulin superfamily 
proteins and play a role in paracellular permeability and cell 
polarity as well as in intracellular signaling regulating cell 
migration. Three isoforms of similar structure have been 
described: JAM-A, B, and C. In the mouse retina, JAM-B was 
recently shown to label an unrecognized class of OFF retinal 
ganglion cells that responds to upward motion.26 JAM-C was 
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Figure 10 Ultrathin sections of the OLM in the fovea of a human retina. (A) Junctions between Müller glia and cones showing typical desmosome structure (inset) with dense 
actin filaments. (B) higher magnification of the glial cell extension between cones. (C) Junctions between cones.
Abbreviation: OLM, outer limiting membrane.
found in the OLM of mouse and human retina at the OLM and 
in the apical processes of retinal Müller glial cells and RPE 
cells as well as in photoreceptors, which suggests a new role 
of JAM-C in the interaction between retinal cells.27 In JAM-C 
knock out mice, JAM-A was overexpressed in the OLM. In 
the monkey retina, JAM-A is highly expressed in the OLM in 
Müller cell apical processes, in cone photoreceptors pedicles, 
and in the SAR of  both rods and cones. Colabeling with a 
Müller cell marker (GS) demonstrates that JAM is located in 
junctions between glial cells and cones in the OLM. The dif-
ferences between JAM isoforms expressed in the mouse and 
the monkey retina can be related to species differences. Inter-
estingly, the location of JAM-A found in the monkey retina is 
very close to the one described for JAM-C in the mouse retina, 
assuming that these isoforms can have redundant activities.
Ultrastructural analysis of the human retina showed that 
homotypic and heterotypic junctions can have different struc-
tures. Particularly, while we could recognize the well-known 
AJ structures linking retinal glial Müller cells to each other, 
a different tight-like structure was observed between Müller 
glia and photoreceptors. The fact that occludin, ZO-1, and JAM 
were found at the OLM are in favor of this hypothesis. We also 
have observed differences in the OLM organization at the fovea, 
where shorter typical desmosomes linked Müller glia and photo-
receptors at the OLM. We also found long Müller glia extension 
in between cone outer segments and tight-like structures at this 
level. This observation needs to be confirmed due to the very 
limited amount of human material available in our study.
Taken together, our results suggest that the OLM can be 
considered as a tight-like junction structure in the retina with 
specific recruitments of TJ and AJ proteins (Figure 9). A similar 
observation was made regarding the junctions between sensory 
and nonsensory cells of the inner ear where a novel hybrid tight 
junction with AJ organization has been described.28 Our pre-
liminary observations tend to show that the junctions between 
glial Müller cells and cones may be of a different nature and 
maybe differently regulated compared to the junctions between 
Müller cells and rods. Obviously, the different structure of 
Müller cone cells in the macula and the specific structure of 
cones suggest that specific molecular link between them and 
RPE cells villosities may exist. The previous observation that 
the monkey fovea contains circumscribed zones of disrupted 
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OLM may be due to the fact that the junctions in the fovea 
can be displaced and look shorter. Further close examination 
of human macula are required to clarify this point.
Finally, we have shown for the first time that during 
diabetic retinopathy, glial Müller cells are not only swollen 
but that they lose their occludin content at the OLM level, 
which leads to cyst formation. These structures are very 
similar to those described clinically and by optical coherence 
tomography suggesting that the OLM junctions could be a 
novel regulatory target in the treatment of macular edema.
In conclusion, our observations are preliminary and will 
be followed by much more extended analysis of the different 
TJ and AJ proteins in the OLM of different species and par-
ticularly of the macula. However, taken together with previous 
work,27,28 they should allow us to rethink the physiopathology 
of macular edema by taking into account the OLM as a real 
“third” barrier that can be disrupted during diseases such as 
diabetic retinopathy.
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